Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$693M |
| 2 |
Constellation Brands
STZ
|
+$368M |
| 3 |
Tesla
TSLA
|
+$332M |
| 4 |
NVIDIA
NVDA
|
+$300M |
| 5 |
Booking.com
BKNG
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$821M |
| 2 |
Netflix
NFLX
|
+$777M |
| 3 |
AbbVie
ABBV
|
+$583M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$477M |
| 5 |
FedEx
FDX
|
+$456M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.29% |
| 2 | Consumer Discretionary | 17.84% |
| 3 | Financials | 13.34% |
| 4 | Healthcare | 12.27% |
| 5 | Communication Services | 11.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Kennametal
KMT
$2.25B
| $489K | ﹤0.01% |
13,619
-17,174
| -56% | -$660K |
|
627
iQIYI
IQ
$888M
| $487K | ﹤0.01% |
15,074
-23,046
| -60% | -$561K |
|
628
Vipshop
VIPS
$6.42B
| $480K | ﹤0.01% |
44,277
+261
| +0.6% | +$3.57K |
|
|
ENDP
629
DELISTED
Endo International plc
ENDP
| $477K | ﹤0.01% |
+50,581
| New | +$340K |
|
630
Piper Sandler
PIPR
$5.34B
| $456K | ﹤0.01% |
23,744
+5,804
| +32% | +$114K |
|
|
OLBK
631
DELISTED
Old Line Bancshares, Inc.
OLBK
| $449K | ﹤0.01% |
+12,852
| New | +$440K |
|
632
Tactile Systems Technology
TCMD
$525M
| $434K | ﹤0.01% |
+8,339
| New | +$363K |
|
633
Qualys
QLYS
$6.47B
| $414K | ﹤0.01% |
4,908
+87
| +2% | +$6.99K |
|
634
Standard BioTools
LAB
$252M
| $410K | ﹤0.01% |
68,791
+28,520
| +71% | +$163K |
|
|
DPLO
635
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
| $409K | ﹤0.01% |
15,988
-1,426
| -8% | -$33.2K |
|
636
Boston Beer
SAM
$1.88B
| $397K | ﹤0.01% |
+1,324
| New | +$323K |
|
637
Shutterstock
SSTK
$221M
| $393K | ﹤0.01% |
8,290
-303
| -4% | -$14.4K |
|
638
Coherus Oncology
CHRS
$218M
| $380K | ﹤0.01% |
27,174
-968
| -3% | -$13.9K |
|
|
B
639
Barrick Mining
B
$75.1B
| $374K | ﹤0.01% |
28,508
+13,140
| +86% | +$172K |
|
640
Power Integrations
POWI
$2.88B
| $346K | ﹤0.01% |
9,466
-1,398
| -13% | -$50.7K |
|
|
COUP
641
DELISTED
Coupa Software Incorporated
COUP
| $345K | ﹤0.01% |
5,547
-573
| -9% | -$30.5K |
|
|
AMRWW
642
DELISTED
Alta Mesa Resources Inc Warrant
AMRWW
| $338K | ﹤0.01% |
241,375
+6,706
| +3% | +$9.95K |
|
643
Baker Hughes
BKR
$62B
| $335K | ﹤0.01% |
+10,132
| New | +$344K |
|
|
CIR
644
DELISTED
CIRCOR International, Inc
CIR
| $324K | ﹤0.01% |
8,757
-318
| -4% | -$14.3K |
|
645
German American Bancorp
GABC
$1.88B
| $321K | ﹤0.01% |
8,950
-329
| -4% | -$11.7K |
|
|
FNSR
646
DELISTED
Finisar Corp
FNSR
| $321K | ﹤0.01% |
17,844
-1,049
| -6% | -$17.4K |
|
|
ABAX
647
DELISTED
Abaxis Inc
ABAX
| $291K | ﹤0.01% |
+3,507
| New | +$269K |
|
|
ORBC
648
DELISTED
ORBCOMM, Inc.
ORBC
| $290K | ﹤0.01% |
+28,686
| New | +$273K |
|
649
RLI Corp
RLI
$5.9B
| $289K | ﹤0.01% |
8,732
-294
| -3% | -$9.67K |
|
650
Trex
TREX
$4.66B
| $284K | ﹤0.01% |
+9,080
| New | +$263K |
|
Similar funds
Jennison Associates's Q2 2018 Portfolio in Review
As of Q2 2018, Jennison Associates held 740 positions worth $103B, up 2% from $101B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Jennison Associates withdrew a net $3.91B in Q2 2018, closing 87 positions and reducing 296 holdings. Its most notable exit was Great Plains Energy Incorporated, an estimated $152M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Jennison Associates opened a new position in AstraZeneca worth $677M.
- Jennison Associates's largest Q2 2018 buy was AstraZeneca: 9,637,084 shares worth $677M.
- Jennison Associates added most to Constellation Brands in Q2 2018, an estimated $368M increase.
- Jennison Associates's biggest Q2 2018 reduction was Charter Communications, cutting an estimated $821M.
- Jennison Associates fully exited Great Plains Energy Incorporated in Q2 2018, selling an estimated $152M.
- Jennison Associates's ten largest holdings make up 29% of its $103B portfolio in Q2 2018.
- Jennison Associates opened 89 new positions and closed 87 in Q2 2018.
- Jennison Associates's portfolio value rose 2% quarter-over-quarter to $103B.
Based on Jennison Associates's 13F filing for Q2 2018, filed 2 Aug 2018.